Literature DB >> 6279640

Genome-length copies of poliovirion RNA are synthesized in vitro by the poliovirus RNA-dependent RNA polymerase.

T A Van Dyke, R J Rickles, J B Flanegan.   

Abstract

A soluble RNA-dependent RNA polymerase was purified from the cytoplasm of poliovirus-infected HeLa cells. A single virus-specific protein designated as p63 (or NCVP4) copurified with this activity. The purified polymerase was free of ribonuclease activity and was shown to copy poliovirion RNA when oligo(U) was added to the in vitro reaction mixture. Characterization of the product RNA by electrophoresis in methylmercury (II) hydroxide-agarose gels showed that genome-sized copies of poliovirion RNA were synthesized in vitro by the purified polymerase. The product RNA was shown to be heteropolymeric, complementary to virion RNA, and covalently linked to oligo(U). The product RNA contained the expected distribution of UMP and GMP containing dinucleotide pairs which included a very low frequency of CpG pairs. The amount, size distribution, and rate of synthesis of product RNA was very dependent on the in vitro reaction conditions. Full sized product RNA was synthesized in about 6 min when reaction conditions were used that yielded maximum elongation rates (pH 8.0, 7 mM Mg2+, 37 degrees C). Under these conditions, most of the product RNA recovered from a 1-h reaction was full sized. Thus, the polymerase was found to specifically initiate synthesis at the 3'-end of the template using an oligo(U) primer and to carry out an elongation reaction at about 1250 nucleotides/min that resulted in the synthesis of full sized product RNA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279640

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Primer-dependent synthesis by poliovirus RNA-dependent RNA polymerase (3D(pol)).

Authors:  V Rodriguez-Wells; S J Plotch; J J DeStefano
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

2.  An Extended Primer Grip of Picornavirus Polymerase Facilitates Sexual RNA Replication Mechanisms.

Authors:  Brian J Kempf; Colleen L Watkins; Olve B Peersen; David J Barton
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

3.  Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C.

Authors:  D J Barton; J B Flanegan
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Expression, purification, and properties of recombinant encephalomyocarditis virus RNA-dependent RNA polymerase.

Authors:  S Sankar; A G Porter
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Direct measurement of the poliovirus RNA polymerase error frequency in vitro.

Authors:  C D Ward; M A Stokes; J B Flanegan
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

6.  Purification of a soluble template-dependent rhinovirus RNA polymerase and its dependence on a host cell protein for viral RNA synthesis.

Authors:  C D Morrow; J Lubinski; J Hocko; G F Gibbons; A Dasgupta
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

7.  Synthesis of plus- and minus-strand RNA from poliovirion RNA template in vitro.

Authors:  T D Hey; O C Richards; E Ehrenfeld
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

8.  In vitro synthesis of infectious poliovirus RNA.

Authors:  G Kaplan; J Lubinski; A Dasgupta; V R Racaniello
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Poliovirus protein 3AB forms a complex with and stimulates the activity of the viral RNA polymerase, 3Dpol.

Authors:  S J Plotch; O Palant
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  ATP is required for initiation of poliovirus RNA synthesis in vitro: demonstration of tyrosine-phosphate linkage between in vitro-synthesized RNA and genome-linked protein.

Authors:  C D Morrow; J Hocko; M Navab; A Dasgupta
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.